AU2002222912A1 - Acyclic isoprenoid ether derivatives as chemotherapuetics - Google Patents

Acyclic isoprenoid ether derivatives as chemotherapuetics

Info

Publication number
AU2002222912A1
AU2002222912A1 AU2002222912A AU2291202A AU2002222912A1 AU 2002222912 A1 AU2002222912 A1 AU 2002222912A1 AU 2002222912 A AU2002222912 A AU 2002222912A AU 2291202 A AU2291202 A AU 2291202A AU 2002222912 A1 AU2002222912 A1 AU 2002222912A1
Authority
AU
Australia
Prior art keywords
chemotherapuetics
ether derivatives
acyclic isoprenoid
acyclic
isoprenoid ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222912A
Inventor
Charles E Elson
Manfred Jung
Huanbiao Mo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of AU2002222912A1 publication Critical patent/AU2002222912A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002222912A 2000-07-18 2001-07-17 Acyclic isoprenoid ether derivatives as chemotherapuetics Abandoned AU2002222912A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21924900P 2000-07-18 2000-07-18
US60/219,249 2000-07-18
PCT/US2001/022469 WO2002005856A2 (en) 2000-07-18 2001-07-17 Acyclic isoprenoid ether derivatives as chemotherapuetics

Publications (1)

Publication Number Publication Date
AU2002222912A1 true AU2002222912A1 (en) 2002-01-30

Family

ID=22818497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222912A Abandoned AU2002222912A1 (en) 2000-07-18 2001-07-17 Acyclic isoprenoid ether derivatives as chemotherapuetics

Country Status (3)

Country Link
US (1) US6566397B2 (en)
AU (1) AU2002222912A1 (en)
WO (1) WO2002005856A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110848A1 (en) * 2002-12-10 2004-06-10 Peffley Dennis M Method and kit for treating cancer
EP3013925B1 (en) * 2013-06-28 2019-08-07 Castrol Limited Lubricating compositions containing isoprene based components

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0570439A (en) * 1991-09-17 1993-03-23 Kao Corp Production of optically active azole derivative
US5466718A (en) * 1993-04-02 1995-11-14 Takasago Institute For Interdisciplinary Tyrosinase inhibitors
US5567729A (en) * 1993-10-28 1996-10-22 David L. Bradfute Farnesyl compounds as farnesyl protein transferase inhibitors to treat ras induced tumor growth
CA2283333A1 (en) 1997-03-04 1998-09-11 Charles E. Elson Method of suppressing tumor growth with combinations of isoprenoids and statins
US6303654B1 (en) * 1998-03-12 2001-10-16 Wisconsin Alumni Research Foundation Acyclic monoterpenoid derivatives

Also Published As

Publication number Publication date
US6566397B2 (en) 2003-05-20
WO2002005856A2 (en) 2002-01-24
WO2002005856A3 (en) 2002-08-29
US20020045584A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001250010A1 (en) Leg press
AU2001271027A1 (en) Ester derivatives
AU2001285338A1 (en) Folding softbox
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001284362A1 (en) Resorcinol derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001236678A1 (en) Adamantyl derivatives as anti-cancer agents
AU2001278790A1 (en) 1h-imidazopyridine derivatives
GB2372749B (en) Crown ether derivatives
AU2001255725A1 (en) Easy cutter
AU2002236477A1 (en) Fgf-affinity chromatography
AU2001264280A1 (en) Vitamin D derivatives
AU2001246992A1 (en) Synchronous compensation
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU5256301A (en) Froindazole derivative
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001256164A1 (en) Chroman derivatives as estrogenic compounds
AU2001248777A1 (en) Vitamin d derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2002218215A1 (en) Novel pleuromutilin derivatives
AU2001284039A1 (en) Chromanone derivatives
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives